Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration. [electronic resource]
Producer: 19920825Description: 1310-6 p. digitalISSN:- 0732-183X
- Acetylmuramyl-Alanyl-Isoglutamine -- analogs & derivatives
- Antineoplastic Agents -- pharmacology
- Biopterins -- analogs & derivatives
- C-Reactive Protein -- drug effects
- Cytokines -- blood
- Drug Carriers
- Drug Evaluation
- Humans
- Liposomes
- Lung Neoplasms -- immunology
- Monocytes, Activated Killer -- drug effects
- Neopterin
- Osteosarcoma -- drug therapy
- Phosphatidylethanolamines -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.